| pubmed-article:19940004 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19940004 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19940004 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:19940004 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:19940004 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19940004 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:19940004 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19940004 | pubmed:dateCreated | 2010-6-24 | lld:pubmed |
| pubmed-article:19940004 | pubmed:abstractText | On the basis of clinical activity of capecitabine and gemcitabine for metastatic breast cancer, we carried out a multicenter phase II clinical trial on the combination of these two agents in advanced anthracycline-pretreated breast cancer patients. Main objectives were to assess its efficacy and safety profile. | lld:pubmed |
| pubmed-article:19940004 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19940004 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19940004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19940004 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19940004 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19940004 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:GarcíaEE | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:MuñozMM | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:MendiolaCC | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:Cortés-FunesH... | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:GómezPP | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:OjedaBB | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:CortésJJ | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:LluchAA | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:MansiJJ | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:BermejoBB | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:MayordomoJ... | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:BaselgaJJ | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:RodríguezC... | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:AndrésRR | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:SauraCC | lld:pubmed |
| pubmed-article:19940004 | pubmed:author | pubmed-author:CiruelosE MEM | lld:pubmed |
| pubmed-article:19940004 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19940004 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:19940004 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19940004 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19940004 | pubmed:pagination | 1442-7 | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:meshHeading | pubmed-meshheading:19940004... | lld:pubmed |
| pubmed-article:19940004 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19940004 | pubmed:articleTitle | Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial). | lld:pubmed |
| pubmed-article:19940004 | pubmed:affiliation | Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain. eciruelos@hotmail.com | lld:pubmed |
| pubmed-article:19940004 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19940004 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19940004 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
